Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK High Court finds cloning loophole:

This article was originally published in Clinica

Executive Summary

A row has erupted in the UK over human cloning following a UK High Court ruling which said that cloning, whether therapeutic or reproductive, can be conducted in the UK without a licence. The court ruled that embryos created by cell nuclear transfer (cloning), as opposed to those created by sperm and egg, are not regulated under UK legislation. The Department of Health plans to appeal against the decision and bring in primary legislation to ban human cloning, while Europe is also tackling the ethics of this subject.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT074172

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel